Related references
Note: Only part of the references are listed.A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma
Maria T. Petrucci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Systems Analysis of BCL2 Protein Family Interactions Establishes a Model to Predict Responses to Chemotherapy
Andreas U. Lindner et al.
CANCER RESEARCH (2013)
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Vincent Ribrag et al.
EUROPEAN JOURNAL OF CANCER (2013)
Activation of executioner caspases is a predictor of progression-free survival in glioblastoma patients: a systems medicine approach
A. C. Murphy et al.
CELL DEATH & DISEASE (2013)
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia
Matthew S. Davids et al.
BLOOD (2012)
Cancer gene therapy targeting cellular apoptosis machinery
Lin-Tao Jia et al.
CANCER TREATMENT REVIEWS (2012)
Relative Mitochondrial Priming of Myeloblasts and Normal HSCs Determines Chemotherapeutic Success in AML
Thanh-Trang Vo et al.
CELL (2012)
Phase II Study of Single-Agent Navitoclax (ABT-263) and Biomarker Correlates in Patients with Relapsed Small Cell Lung Cancer
Charles M. Rudin et al.
CLINICAL CANCER RESEARCH (2012)
The central role of initiator caspase-9 in apoptosis signal transduction and the regulation of its activation and activity on the apoptosome
Maximilian L. Wuerstle et al.
EXPERIMENTAL CELL RESEARCH (2012)
Clinical application of a systems model of apoptosis execution for the prediction of colorectal cancer therapy responses and personalisation of therapy
Suzanne Hector et al.
GUT (2012)
Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A structured approach to the study of metabolic control principles in intact and impaired mitochondria
Heinrich J. Huber et al.
MOLECULAR BIOSYSTEMS (2012)
TRAIL Signaling and Synergy Mechanisms Used in TRAIL-Based Combination Therapies
Christian T. Hellwig et al.
MOLECULAR CANCER THERAPEUTICS (2012)
A Death Effector Domain Chain DISC Model Reveals a Crucial Role for Caspase-8 Chain Assembly in Mediating Apoptotic Cell Death
Laura S. Dickens et al.
MOLECULAR CELL (2012)
Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model
Kolja Schleich et al.
MOLECULAR CELL (2012)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Exploring the Contextual Sensitivity of Factors that Determine Cell-to-Cell Variability in Receptor-Mediated Apoptosis
Suzanne Gaudet et al.
PLOS COMPUTATIONAL BIOLOGY (2012)
Approaches for targeting mitochondria in cancer therapy
Gerard G. M. D'Souza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2011)
Mathematical modelling of the mitochondrial apoptosis pathway
Heinrich J. Huber et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Mitochondrial outer membrane permeabilization during apoptosis: The role of mitochondrial fission
Thomas Landes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Heterogeneity reduces sensitivity of cell death for TNF-Stimuli
Monica Schliemann et al.
BMC SYSTEMS BIOLOGY (2011)
Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity
Ravi K. Amaravadi et al.
CANCER RESEARCH (2011)
Measuring and Modeling Apoptosis in Single Cells
Sabrina L. Spencer et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Systems Biology of Apoptosis and Survival: Implications for Drug Development
Salvatore Pezzino et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases
Andreas Strasser et al.
EMBO JOURNAL (2011)
Double-Blind, Placebo-Controlled, Randomized Phase 2 Study of the Proapoptotic Agent AT-101 Plus Docetaxel, in Second-Line Non-small Cell Lung Cancer
Neal Ready et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
A Phase II Study of AT-101 (Gossypol) in Chemotherapy-Sensitive Recurrent Extensive-Stage Small Cell Lung Cancer
Maria Q. Baggstrom et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
Fabien Llambi et al.
MOLECULAR CELL (2011)
Glucose metabolism determines resistance of cancer cells to bioenergetic crisis after cytochrome-c release
Heinrich J. Huber et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
Lyapunov exponents and phase diagrams reveal multi-factorial control over TRAIL-induced apoptosis
Bree B. Aldridge et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Paul K. Paik et al.
LUNG CANCER (2011)
Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy
Triona Ni Chonghaile et al.
SCIENCE (2011)
Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation
A. M. M. Kober et al.
CELL DEATH & DISEASE (2011)
Diffusion is capable of translating anisotropic apoptosis initiation into a homogeneous execution of cell death
Heinrich J. Huber et al.
BMC SYSTEMS BIOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Targeting Mitochondria for Cancer Therapy
David M. Hockenbery
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2010)
The Caspase-8 Dimerization/Dissociation Balance Is a Highly Potent Regulator of Caspase-8,-3,-6 Signaling
Maximilian L. Wuerstle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL
Nicolai Fricker et al.
JOURNAL OF CELL BIOLOGY (2010)
Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
Rebecca Suk Heist et al.
Journal of Thoracic Oncology (2010)
The BCL-2 Family Reunion
Jerry E. Chipuk et al.
MOLECULAR CELL (2010)
Dynamics within the CD95 death-inducing signaling complex decide life and death of cells
Leo Neumann et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
Targeting mitochondria for cancer therapy
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Systems biology analysis of programmed cell death
Shani Bialik et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
A Technical Assessment of the Utility of Reverse Phase Protein Arrays for the Study of the Functional Proteome in Non-microdissected Human Breast Cancers
Bryan T. Hennessy et al.
Clinical Proteomics (2010)
Dynamics of outer mitochondrial membrane permeabilization during apoptosis
M. Rehm et al.
CELL DEATH AND DIFFERENTIATION (2009)
An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
Glenn Liu et al.
CLINICAL CANCER RESEARCH (2009)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Expression of X-Linked Inhibitor of Apoptosis Protein in Human Colorectal Cancer and Its Correlation With Prognosis
Xiang Guoan et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
Sabrina L. Spencer et al.
NATURE (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intracellular signaling dynamics during apoptosis execution in the presence or absence of X-linked-inhibitor-of-apoptosis-protein
Carla L. O'Connor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Quantitative analysis of pathways controlling extrinsic apoptosis in single cells
John G. Albeck et al.
MOLECULAR CELL (2008)
BCL-2 family antagonists for cancer therapy
Guillaume Lessene et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
K-ras mutations and benefit from cetuximab in advanced colorectal cancer
Christos S. Karapetis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death
John G. Albeck et al.
PLOS BIOLOGY (2008)
Cetuximab for the treatment of colorectal cancer
Derek J. Jonker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
c-Myc blazing a trail of death - Coupling of the mitochondrial and death receptor apoptosis pathways by c-Myc
Anni I. Nieminen et al.
CELL CYCLE (2007)
Analysis of CD95 threshold signaling - Triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling
Inna N. Lavrik et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes
Brian Leber et al.
APOPTOSIS (2007)
APOPTO-CELL -: a simulation tool and interactive database for analyzing cellular susceptibility to apoptosis
Heinrich J. Huber et al.
BIOINFORMATICS (2007)
Apoptosis induced by proteasome inhibition in cancer cells:: predominant role of the p53/PUMA pathway
C. G. Concannon et al.
ONCOGENE (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Profiling of apoptosis genes allows for clinical stratification of primary nodal diffuse large B-cell lymphomas
J. J. F. Muris et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Decreased internalisation of ErbB1 mutants in lung cancer is linked with a mechanism conferring sensitivity to gefitinib
B. S. Hendriks et al.
IEE PROCEEDINGS SYSTEMS BIOLOGY (2006)
Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein
Markus Rehm et al.
EMBO JOURNAL (2006)
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
S. Fulda et al.
ONCOGENE (2006)
Dexamethasone inhibits apoptosis in C6 glioma cells through increased expression of Bcl-XL
Triona Ni Chonghaile et al.
APOPTOSIS (2006)
Ewing's sarcoma family of tumors: Current management
Mark Bernstein et al.
ONCOLOGIST (2006)
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members
Michael Certo et al.
CANCER CELL (2006)
The predictive value of apoptosis protease-activating factor 1 in rectal tumors treated with preoperative, high-dose-rate brachytherapy
I Zlobec et al.
CANCER (2006)
Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability
Stefan Legewie et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers
M Krajewska et al.
CLINICAL CANCER RESEARCH (2005)
Effects of Bcl-2 levels on Fas signaling-induced caspase-3 activation: Molecular genetic tests of computational model predictions
F Hua et al.
JOURNAL OF IMMUNOLOGY (2005)
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis
M Bentele et al.
JOURNAL OF CELL BIOLOGY (2004)
Bistability analyses of a caspase activation model for receptor-induced apoptosis
T Eissing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The pathophysiology of mitochondrial cell death
DR Green et al.
SCIENCE (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Real-time single cell analysis of Smac/DIABLO release during apoptosis
M Rehm et al.
JOURNAL OF CELL BIOLOGY (2003)
XIAP inhibition of caspase-3 preserves its association with the Apaf-1 apoptosome and prevents CD95-and Bax-induced apoptosis
SB Bratton et al.
CELL DEATH AND DIFFERENTIATION (2002)
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
A Letai et al.
CANCER CELL (2002)
Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process -: Role of caspase-3
M Rehm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process
NJ Waterhouse et al.
JOURNAL OF CELL BIOLOGY (2001)
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis
SM Srinivasula et al.
NATURE (2001)
Structural basis of IAP recognition by Smac/DIABLO
G Wu et al.
NATURE (2000)
A mathematical model of caspase function in apoptosis
M Fussenegger et al.
NATURE BIOTECHNOLOGY (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
The coordinate release of cytochrome c during apoptosis is rapid, complete and kinetically invariant
JC Goldstein et al.
NATURE CELL BIOLOGY (2000)
Share Paper
